Literature DB >> 6414941

Platelet-activating factor.

R N Pinckard.   

Abstract

Our ability to chemically characterize and synthesize this autacoid of allergy and inflammation has given us a unique opportunity to study these important molecules in a highly disciplined fashion. It has also opened the door to a vista of research approaches to define PAF's normal physiologic role as well as its actions as an immunopathologic mediator. Recent work is described.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6414941     DOI： 10.1080/21548331.1983.11702680

Source DB:  PubMed          Journal:  Hosp Pract (Off Ed)        ISSN： 8750-2836


  5 in total

1.  The Protective Effect of SRI 63-441 on Ischemic Liver Injury Using the Isolated Perfused Rat Liver: Combined Protocol With Superoxide Dismutase.

Authors:  S J Ontell; L Makowka; V Mazzaferro; J Trager; P Ove; T E Staral
Journal:  Transplant Proc       Date:  1988-02-01       Impact factor: 1.066

2.  Pharmacologic modulation of experimental postischemic hepatic function.

Authors:  S J Ontell; L Makowka; J Trager; V Mazzaferro; P Ove; T E Starzl
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

3.  Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium. Time course and dose-response relationships.

Authors:  P K Dillon; M F Fitzpatrick; A B Ritter; W N Durán
Journal:  Inflammation       Date:  1988-12       Impact factor: 4.092

4.  Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441.

Authors:  S J Ontell; L Makowka; P Ove; T E Starzl
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

5.  Allergy-important advances in clinical medicine: platelet-activating factor.

Authors:  R S Farr
Journal:  West J Med       Date:  1984-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.